Iodine | Placebo | Treatment effect (95 % CI) | P value | |
---|---|---|---|---|
Pregnancy outcome | n = 29 | n = 29 | ||
Miscarriagea | 1 (3.5) | 0 (0.0) | N/A | >0.99 |
Stillbirtha | 0 (0.0) | 0 (0.0) | N/A | N/A |
Caesarean sectiona | 9 (32.1) | 5 (17.2) | N/A | 0.19 |
Post-term inductiona | 3 (10.7) | 4 (13.8) | N/A | >0.99 |
Gestational diabetesa | 1 (3.6) | 2 (6.9) | N/A | >0.99 |
Pregnancy-induced hypertensiona | 0 (0.0) | 0 (0.0) | N/A | N/A |
Pre-eclampsiaa | 0 (0.0) | 0 (0.0) | N/A | N/A |
Antenatal hospital admissiona | 6 (22.2) | 7 (24.1) | N/A | 0.87 |
Neonatal outcome | n = 28 | n = 29 | ||
GA at birth, weeksb | 39.3 (37.8 – 40.4) | 39.7 (39.3 – 40.3) | N/A | 0.23 |
Preterm birth, GA < 37 weeksa | 5 (17.9) | 4 (13.8) | N/A | 0.73 |
Birth weight, gc | 3325.4 (474.7) | 3204.3 (689.4) | 121.1 (−194.2, 436.3) | 0.45 |
Birth length, cmc | 49.4 (2.3) | 48.7 (3.3) | 0.7 (−0.9, 2.2) | 0.37 |
Birth head circumference, cmc | 34.6 (1.3) | 33.9 (2.2) | 0.7 (−0.3, 1.7) | 0.15 |
Placental weight, gc | 533.5 (136.2) | 514.4 (129.5) | 19.1 (−114.9, 153.2) | 0.77 |
Low birth weight, <2500 ga | 1 (3.6) | 3 (10.3) | N/A | 0.61 |
SGAa | 3 (10.7) | 2 (6.9) | N/A | 0.67 |
LGAa | 2 (7.1) | 4 (13.8) | N/A | 0.67 |
Major congenital abnormalitya | 0 (0.0) | 0 (0.0) | N/A | N/A |
Neonatal complicationa | 5 (17.9) | 5 (17.2) | N/A | >0.99 |
Admission to NICUa | 0 (0.0) | 2 (6.9) | N/A | 0.49 |
Neonatal deatha | 0 (0.0) | 0 (0.0) | N/A | N/A |